News Release

Zogenix to Participate in the Wells Fargo 2015 Healthcare Conference


SAN DIEGO, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced that Stephen J. Farr, Ph.D., President and CEO, will present a corporate update at the Wells Fargo 2015 Healthcare Conference in Boston, MA, on September 10, 2015.

Wells Fargo 2015 Healthcare Conference
Date: Thursday, September 10, 2015
Time: 8:35 am Eastern Time / 5:35 am Pacific Time
Location: Boston, MA - Hyatt Regency, Room 2

The presentation will be webcast live and archived for 30 days on Zogenix's Investor Relations website at

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.

For more information, visit

CONTACT: Investors: Andrew McDonald
         Founding Partner, LifeSci Advisors LLC
         646-597-6987 |
Zogenix, Inc.